Concepedia

Muthu Dhandapani

MD

Statistics

Publications

5

Citations

438

H-Index

5

Active since

2013

Affiliations

Mitra Biotech (India)(Current)

Harvard University

Brigham and Women's Hospital

Muthu Dhandapani is an author at Mitra Biotech (India) specializing in medicine, cancer biomarkers, and oncology.

Publications per year

2013–2018

5

Publications

5

Predicting clinical response to anticancer drugs using an ex vivo platform that captures tumour heterogeneity

Biswanath Majumder, Ulaganathan Baraneedharan, Saravanan Thiyagarajan et al. · Nature Communications · 2015 · 310 citations · Full text

, , +17

Preclinical Cancer Models and Biomarkers for Drug Development: New Technologies and Emerging Tools

Muthu Dhandapani, Aaron Goldman · Journal of Molecular Biomarkers & Diagnosis · 2017 · 52 citations · Full text

, , +17

Predicting Tumor Sensitivity to Chemotherapeutic Drugs in Oral Squamous Cell Carcinoma Patients

Beaulah Mary Robert, Muralidharan Dakshinamoorthy, Muthu Dhandapani et al. · Scientific Reports · 2018 · 31 citations · Full text

, , +17

Rationally co-targeting divergent pathways in KRAS wild-type colorectal cancers by CANscript technology reveals tumor dependence on Notch and Erbb2

Nilesh Brijwani, Misti Jain, Muthu Dhandapani et al. · Scientific Reports · 2017 · 23 citations · Full text

, , +17

Inhibition of Rapamycin-Induced AKT Activation Elicits Differential Antitumor Response in Head and Neck Cancers

Padhma Radhakrishnan, Ulaganathan Baraneedharan, Subhadra Veluchamy et al. · Cancer Research · 2013 · 22 citations

, , +17

1–5 of 5